.png){kind=logo}
Statistics
Total Visits
| Views | |
|---|---|
| Deucravacitinib, ... | 26 |
Total Visits per Month
| junio 2025 | julio 2025 | agosto 2025 | septiembre 2025 | octubre 2025 | noviembre 2025 | diciembre 2025 | |
|---|---|---|---|---|---|---|---|
| Deucravacitinib, ... | 0 | 0 | 0 | 0 | 0 | 4 | 22 |
File Downloads
| Views | |
|---|---|
| 7_2023_Deucravacitinib a tyrosine kinase 2 pseudokinase inhibitor protects human EndoC-betaH1_beta_cells against proinflammatory insults.pdf | 11 |
Top Country Views
| Views | |
|---|---|
| Estados Unidos | 12 |
| Brasil | 4 |
| Suiza | 1 |
| Colombia | 1 |
| Alemania | 1 |
| Reino Unido | 1 |
| India | 1 |
| Iraq | 1 |
| Letonia | 1 |
| Palestina | 1 |
Top City Views
| Views | |
|---|---|
| Baghdad | 1 |
| Belo Horizonte | 1 |
| Daugavpils | 1 |
| Jaú | 1 |
| London | 1 |
| Manizales | 1 |
| Nova Iguaçu | 1 |